Cargando…

Interplay between RNA Viruses and Promyelocytic Leukemia Nuclear Bodies

Promyelocytic leukemia nuclear bodies (PML NBs) are nuclear membrane-less sub structures that play a critical role in diverse cellular pathways including cell proliferation, DNA damage, apoptosis, transcriptional regulation, stem cell renewal, alternative lengthening of telomeres, chromatin organiza...

Descripción completa

Detalles Bibliográficos
Autor principal:	Neerukonda, Sabari Nath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065607/ https://www.ncbi.nlm.nih.gov/pubmed/33807177 http://dx.doi.org/10.3390/vetsci8040057

Ejemplares similares

Avian Pattern Recognition Receptor Sensing and Signaling
por: Neerukonda, Sabari Nath, et al.
Publicado: (2020)

A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
por: Neerukonda, Sabari Nath, et al.
Publicado: (2020)

Functional Reorganization of Promyelocytic Leukemia Nuclear Bodies during BK Virus Infection
por: Jiang, Mengxi, et al.
Publicado: (2011)

Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA
por: Boisvert, François-Michel, et al.
Publicado: (2000)

Targeting Promyelocytic Leukemia Protein: A Means to Regulating PML Nuclear Bodies
por: Reineke, Erin L., et al.
Publicado: (2009)

The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection
por: Guion, Lucile G., et al.
Publicado: (2020)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions
por: Wang, Jayson, et al.
Publicado: (2004)

Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies
por: Hirano, Seishiro, et al.
Publicado: (2022)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
por: Nath Neerukonda, Sabari, et al.
Publicado: (2020)

Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge
por: Badarkhe, Girish V., et al.
Publicado: (2016)

The Transcription Coactivator Cbp Is a Dynamic Component of the Promyelocytic Leukemia Nuclear Body
por: Boisvert, François-Michel, et al.
Publicado: (2001)

Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes
por: Udagawa, Osamu, et al.
Publicado: (2022)

Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy
por: Thangaraju, Kiruphagaran, et al.
Publicado: (2020)

Manipulation of Promyelocytic Leukemia Protein Nuclear Bodies by Marek’s Disease Virus Encoded US3 Protein Kinase
por: Liao, Yifei, et al.
Publicado: (2021)

Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease
por: Shishido-Hara, Yukiko
Publicado: (2010)

Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
por: Yoon, G. S., et al.
Publicado: (2001)

Identifying gene locus associations with promyelocytic leukemia nuclear bodies using immuno-TRAP
por: Ching, Reagan W., et al.
Publicado: (2013)

The interaction between herpes simplex virus 1 genome and promyelocytic leukemia nuclear bodies (PML-NBs) as a hallmark of the entry in latency
por: Lomonte, Patrick
Publicado: (2016)

History of Acute Promyelocytic Leukemia
por: Sanz, Miguel A., et al.
Publicado: (2021)

Multimodal Light Microscopy Approaches to Reveal Structural and Functional Properties of Promyelocytic Leukemia Nuclear Bodies
por: Hoischen, Christian, et al.
Publicado: (2018)

ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
por: Hofmann, Samuel, et al.
Publicado: (2020)

Comparison of the Transcriptomes and Proteomes of Serum Exosomes from Marek’s Disease Virus-Vaccinated and Protected and Lymphoma-Bearing Chickens
por: Neerukonda, Sabari Nath, et al.
Publicado: (2019)

A Novel Inclusion Body in Acute Promyelocytic Leukemia
por: Dong, Shu-xu, et al.
Publicado: (2023)

Advances in Pediatric Acute Promyelocytic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification
por: Tatemichi, Yoshinori, et al.
Publicado: (2015)

Identification of Key Proteins from the Alternative Lengthening of Telomeres-Associated Promyelocytic Leukemia Nuclear Bodies Pathway
por: Armendáriz-Castillo, Isaac, et al.
Publicado: (2022)

Epstein - Barr virus latent membrane protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies
por: Sides, Mark D, et al.
Publicado: (2011)

Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies
por: Tavalai, Nina, et al.
Publicado: (2009)

SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA
por: Hofmann, Samuel, et al.
Publicado: (2023)

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults
por: Testi, Anna Maria, et al.
Publicado: (2014)

Management of Acute Promyelocytic Leukemia in the Elderly
por: Lo-Coco, Francesco, et al.
Publicado: (2013)

Acute Promyelocytic Leukemia: A Summary
por: Ryan, Meaghan M.
Publicado: (2018)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein
por: Jul-Larsen, Åsne, et al.
Publicado: (2010)

Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas
por: Matsuo, Toshihiro, et al.
Publicado: (2008)

Pancreatitis in Acute Promyelocytic Leukemia: Drug-induced or Differentiation Syndrome?
por: De, Dibyendu, et al.
Publicado: (2017)

A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity
por: Patra, Upayan, et al.
Publicado: (2021)

Management of Acute Promyelocytic Leukemia at Extremes of Age
por: Kayser, Sabine, et al.
Publicado: (2023)

The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells
por: Huber, Andrew D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1e2mj81mtqhna4v1ghm16l5egv